PLSE — Pulse Biosciences Balance Sheet
0.000.00%
- $977.20m
- $942.32m
- 34
- 15
- 85
- 41
Annual balance sheet for Pulse Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 25.4 | 20.5 | 28.6 | 61.1 | 44.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 0.061 | 0 | — |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 26.4 | 22.3 | 36.6 | 62.1 | 45.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7.68 | 11.9 | 11.2 | 10 | 8.78 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 41.9 | 41.3 | 54.2 | 77.9 | 59.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.46 | 7.58 | 8.52 | 5.98 | 6.71 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 11.2 | 18.4 | 18.6 | 80.1 | 14.8 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 30.7 | 22.9 | 35.7 | -2.25 | 44.4 |
Total Liabilities & Shareholders' Equity | 41.9 | 41.3 | 54.2 | 77.9 | 59.2 |
Total Common Shares Outstanding |